Pfizer Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Feb 13, 2026
  • 17 Class I recalls
  • Last warning letter 2012
Inspections 47 2 OAI
Recalls 129 17 Class I (13%)
Warning letters 3 Latest May 24, 2012
510(k) clearances 30 Latest Sep 15, 2018

Pfizer Inc. has 129 FDA recalls (17 Class I), 47 inspections, 30 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to Pfizer Inc., the most recent on May 24, 2012. FDA has published 1 Form 483 for Pfizer Inc..

What these totals cover: FDA records filed under the name "Pfizer Inc." and its spelling variant "Pfizer". Records filed under related names are not included; see Related names.

Latest recall
D-0052-2027 · Class II · Sep 29, 2026
Latest inspection
Feb 13, 2026 · NAI
Latest 510(k)
Sep 15, 2018

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls129 (17 Class I)Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026Current
510(k) clearances30Nov 22, 2026File dated Nov 18, 2026Current
Inspections47Nov 22, 2026Newest record Nov 9, 2026Current
Compliance actions3Nov 22, 2026Newest record Nov 13, 2026Current

FDA record by year

Pfizer Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Pfizer Inc.: FDA inspections per year

2017: 4 inspections (0 OAI), 0 warning letters, 12 recall records (2 Class I) 2018: 3 inspections (0 OAI), 0 warning letters, 12 recall records (2 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 16 recall records (1 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 7 recall records (0 Class I) 2021: 3 inspections (0 OAI), 0 warning letters, 11 recall records (2 Class I) 2022: 3 inspections (0 OAI), 0 warning letters, 16 recall records (3 Class I) 2023: 2 inspections (0 OAI), 0 warning letters, 8 recall records (7 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2025: 3 inspections (0 OAI), 0 warning letters, 6 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 3 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610030
202530060
202400020
202320087
2022300163
2021300112
202000070
2019100161
2018300122
2017400122

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Pfizer Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Pfizer Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Pfizer Inc. FDA Warning Letters

3 warning letters from Apr 9, 2010 to May 24, 2012.

IssuedSubjectIssuing officeClose-out letter
May 24, 2012 · Record page
May 26, 2010 · Record page
Apr 9, 2010 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Pfizer Inc. Form 483s

1 Form 483 published by FDA.

DateDocumentFEI
Jul 23, 2015 · Document on fda.gov 4831876582

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

129 recall records from Nov 26, 2012 to Sep 29, 2026. Showing the 20 most recent. View all 129 recall records

NumberClassProductDate
D-0052-2027Class IILevoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only…Sep 29, 2026
D-0051-2027Class IILevoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only…Sep 29, 2026
D-0853-2026Class IIDopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only…Sep 4, 2026
D-0590-2025Class IIVial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc…Aug 4, 2025
D-0591-2025Class IIVial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc…Aug 4, 2025
D-0575-2025Class IILevoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by…Jul 29, 2025
D-0545-2025Class IIBicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx…Jul 10, 2025
D-0544-2025Class IIBicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx…Jul 10, 2025
D-0489-2025Class IIDOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10…May 28, 2025
D-0564-2024Class IIBuprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge…May 20, 2024
D-0565-2024Class IILabetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile…May 20, 2024
D-0234-2024Class I8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of…Dec 21, 2023
D-0235-2024Class IAtropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use…Dec 21, 2023
D-0261-2024Class IBleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only…Dec 21, 2023
D-0233-2024Class I4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe…Dec 21, 2023
D-0101-2024Class I1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as…Oct 2, 2023
D-0100-2024Class I4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5mEq/mL), Glass ABBOJECT Unit of Use Syringe…Oct 2, 2023
D-0102-2024Class I2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as…Oct 2, 2023
D-0532-2023Class IIIMEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma…Mar 8, 2023
D-0097-2023Class IIHeparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection…Dec 29, 2022

Recent FDA inspections

47 inspections from Oct 1, 2008 to Feb 13, 2026. Showing the 20 most recent. View all 47 inspections

DateSiteProductClassificationFEI
Feb 13, 2026San Diego, CABiologicsNo Action Indicated (NAI)3001433984
Oct 24, 2025Groton, CTDrugsVoluntary Action Indicated (VAI)1211022
Aug 22, 2025San Diego, CADrugsNo Action Indicated (NAI)3001433984
Jun 18, 2025Parsippany, NJDrugsNo Action Indicated (NAI)3003836868
May 5, 2023San Diego, CADrugsNo Action Indicated (NAI)3001433984
Apr 19, 2023Groton, CTDrugsNo Action Indicated (NAI)1211022
Oct 28, 2022Groton, CTDrugsNo Action Indicated (NAI)1211022
Sep 28, 2022Parsippany, NJDrugsNo Action Indicated (NAI)3003836868
Jul 22, 2022New York, NYDrugsNo Action Indicated (NAI)2416101
Nov 19, 2021Groton, CTDrugsNo Action Indicated (NAI)1211022
Jun 4, 2021Groton, CTDrugsNo Action Indicated (NAI)1211022
Jan 8, 2021Groton, CTBiologicsNo Action Indicated (NAI)1211022
Aug 20, 2019Chesterfield, MODrugsNo Action Indicated (NAI)1940118
Nov 2, 2018Groton, CTDrugsNo Action Indicated (NAI)1211022
Oct 5, 2018Groton, CTDrugsNo Action Indicated (NAI)1211022
Jun 21, 2018Groton, CTDrugsVoluntary Action Indicated (VAI)1211022
Sep 8, 2017Peapack, NJDrugsNo Action Indicated (NAI)3004945409
Jun 28, 2017Groton, CTDrugsVoluntary Action Indicated (VAI)1211022
Jun 7, 2017Groton, CTDrugsVoluntary Action Indicated (VAI)1211022
Jan 12, 2017Groton, CTDrugsNo Action Indicated (NAI)1211022
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 3 compliance actions under Pfizer Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, May 24, 2012.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

9 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3001433984San Diego, CA3Feb 13, 2026
FEI 1211022Groton, CT22Oct 24, 2025
FEI 3003836868Parsippany, NJ5Jun 18, 2025
FEI 2416101New York, NY5Jul 22, 2022
FEI 1940118Chesterfield, MO4Aug 20, 2019
FEI 3004945409Peapack, NJ3Sep 8, 2017
FEI 3005078489Cary, NC2Aug 25, 2011
FEI 1819598Terre Haute, IN2Jun 24, 2010
FEI 2410924Brooklyn, NY1Oct 1, 2008

Recent 510(k) clearances

30 510(k) clearances from Jun 8, 1977 to Sep 15, 2018. Showing the 20 most recent. View all 30 510(k) clearances

K-NumberDeviceDate
K181102ThermaCare Quick Therapy TENSSep 15, 2018
K991620VISINE FOR CONTACTSSep 24, 1999
K892264ORALCHEK SUPER-SOFT BRUSHJun 14, 1989
K892360WATER JEL STERILE GEL-SOAKED BURN DRESSINGJun 5, 1989
K881378PFIZER HOSPITAL PRODUCTS GROUP ACL DRILL GUIDEJun 17, 1988
K854726MEDI-WIPES UNITED ANTISEPTIC SKIN PREPFeb 24, 1986
K850443MEC ROD CONNECTORJul 15, 1985
K850840HOWMEDICA THREADED ACETABULAR COMPONENTJul 15, 1985
K850413MEC HIP BOLTJul 15, 1985
K850403MEC DISTAL FEMORAL BOLTJul 15, 1985
K851971SERIES 7000/HOLTER RECORDERJun 20, 1985
K852041DEKNATEL THORACIC CATHETERJun 17, 1985
K851024PLEUR-EVAC AUTOTRANSFUSION SYSTEM -TENTATIVEMay 23, 1985
K850441MEC INTRAMEDULLARY RODApr 19, 1985
K850886COMPRESSION HIP SCREW SYSTEMApr 19, 1985
K850401LETOURNEL ACETABULAR PLATEApr 19, 1985
K850444MEC BUTRESS PLATEApr 19, 1985
K850442MEC BROAD BONE PLATEApr 19, 1985
K844938UNITED SKIN BARRIERSJan 18, 1985
K792349SUSCEPTIBILITY DISK, CINOXACIN 100 MCG.Mar 12, 1980

Pfizer Inc. and the FDA: common questions

Has Pfizer Inc. received an FDA warning letter?

Yes. FDA has issued 3 warning letters to Pfizer Inc.. The most recent is dated May 24, 2012.

Has Pfizer Inc. received an FDA Form 483?

FDA has published 1 Form 483 for Pfizer Inc. in its reading room, the most recent dated Jul 23, 2015. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Pfizer Inc.?

The most recent FDA inspection on file ended Feb 13, 2026 at San Diego, CA and was classified NAI. FDA has 47 inspections of Pfizer Inc. on file, 2 of them classified OAI (official action indicated).

Has Pfizer Inc. had an FDA recall?

Yes. Pfizer Inc. has 129 FDA recalls on record, 17 of them Class I, the most serious class. The most recent started Sep 29, 2026.

Need more than this page shows? Ask about Pfizer Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.